Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | GSK3B | P49841 | 2/20 | 0.55 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3868073 | 0.93 | MAPT (0.63) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6202777 | 0.91 | MAPT (0.64) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6318934 | 0.91 | MAPT (0.78) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6319805 | 0.91 | MAPT (0.68) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6321338 | 0.91 | MAPT (0.64) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6326562 | 0.91 | LMNA (0.64) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6328277 | 0.91 | MAPT (0.64) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6204121 | 0.91 | LMNA (0.64) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL6205126 | 0.91 | L3MBTL1 (0.60) | MAPTLMNAKDM4EL3MBTL1RAB9A | |
| SCHEMBL658106 | 0.91 | MAPT (0.64) | MAPTLMNAKDM4EL3MBTL1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903453-A | Recycling method of 2-chloro-4- (4-chlorophenoxy) acetophenone raffinate | 浙江宇龙生物科技股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-120682090-A | Recycling treatment method for 2-chloro-4- (4-chlorophenoxy) acetophenone raffinate | 甘肃贝达生物科技有限公司 | 2025-09-23 | — | — | CN | disclosed |
| CN-116903453-A | Recycling method of 2-chloro-4- (4-chlorophenoxy) acetophenone raffinate | 浙江宇龙生物科技股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116903453-A | Recycling method of 2-chloro-4- (4-chlorophenoxy) acetophenone raffinate | 浙江宇龙生物科技股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20050272036-A1 | Ketones | ASTRAZENECA AB (SE) | 2005-12-08 | — | — | US | disclosed |
| CN-1681763-A | Chemical compounds | ASTRAZENECA AB (SE) | 2005-10-12 | — | — | CN | disclosed |
| US-20050107457-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SINGNAL PHARMACEUTICALS, INC. | 2005-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107457-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | MAP3K7, MAP3K1, MAP3K8 | MAPT 978/4885LMNA 2859/4885KDM4E 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.